Similar content being viewed by others Subjects Facts Iron overload in the body increases the risk of developing diabetes
Wegovy is the brand name for a once a week, injectable version of semaglutide produced by Novo Nordisk for the treatment of obesity
has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
Because of its interaction with metabolic enzymes, the compound is frequently used in laboratory models examining cellular metabolism, enzymatic regulation, and biochemical pathway signaling related to energy homeostasis